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MicroRNAs (miRNAs) are small 19–23 nucleotide regulatory RNAs that function by
modulatingmRNA translation and/or turnover in a sequence-speciﬁc fashion. In the nervous
system, miRNAs regulate the production of numerous proteins involved in synaptic
transmission. In turn, neuronal activity can regulate the production and turnover of miRNA
through a variety of mechanisms. In this way, miRNAs and neuronal activity are in a
reciprocal homeostatic relationship that balances neuronal function. The miRNA function
is critical in pathological states related to overexcitation such as epilepsy and stroke,
suggesting miRNA’s potential as a therapeutic target. We review the current literature
relating the interplay of miRNA and neuronal activity and provide future directions for
deﬁning miRNA’s role in disease.
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MicroRNAs are endogenously encoded small RNAs that are pro-
cessed sequentially into mature 19–23 nucleotide (nt) regulatory
molecules (Krol et al., 2010b). Once processed to their mature
length, miRNAs are bound by the core component of the RNA-
induced silencing complex (RISC), the PIWI-domain containing
protein Argonaute (AGO). In mammals, there are four mem-
bers of the Argonaute family (AGO1–4), all of which are capable
of silencing mRNAs in a miRNA-dependent fashion. Of these
AGO family members, only AGO2 is capable of directly catalyz-
ing endonucleolytic cleavage of RNA targets, and only when there
is complete complementarity between the miRNA and its target
(Filipowicz et al., 2008). The AGO2-mediated cleavage of target
RNAs is thought to be the primary effector of the exogenously
supplied small interfering RNA (siRNA) or short hairpin RNA
(shRNA). Most endogenous miRNA–mRNA interactions differ in
two important ways (Bartel, 2009). First, most miRNAs share only
partial complementarity with their mRNA targets, guiding RISC
to its targets through interaction between the 5′-most 6–8 nt of the
miRNA (the so-called seed sequence) and its mRNA target, usually
in the 3′ untranslated region (3′ UTR). Second, though essen-
tial for miRNA-mediated silencing, AGO does not directly cleave
mRNA targets. Instead, the AGO–miRNA complex recruits a host
of additional factors that result in the silencing of mRNA targets.
The mechanism by which miRNAs silence their mRNA targets
remains highly controversial (Filipowicz et al., 2008; Djuranovic
et al., 2011). There are two primary camps in the mechanism of
silencing debate. One camp believes that mRNA silencing by miR-
NAs occurs completely by mRNA deadenylation and decay. The
other camp does not dispute that RISC can catalyze deadenylation
and decay of targets, but believes there is an element of transla-
tional repression that precedes the destruction of target messages.
Not surprisingly, there are excellent experiments that support both
of these models that fuel this ongoing debate in the literature. This
debate lies beyond the scope of this review, but remains impor-
tant especially when considering how miRNAs sculpt neuronal
function.
There are numerousways inwhichmiRNAsmodulate the func-
tion of the nervous system. A variety of studies have shown how
miRNA plays an important role in the development and in a
wide array of disorders of the nervous system (Sun et al., 2013).
The focus of this review is the interplay of miRNA and neuronal
activity.
miRNAs REGULATE STRUCTURAL AND SYNAPTIC
PLASTICITY
Regulation of neuronal excitability is a major control point for
synaptic plasticity, a fundamental component of learning and
memory. Alterations in synaptic function are associated with both
structural changes at the synapse and changes in synaptic strength
(Figure 1). Structural changes at the synapse are commonly associ-
ated with alterations in the cytoskeletal function, leading either to
the establishment or dissolution of synapses (Bosch and Hayashi,
2012; Rochefort and Konnerth, 2012). Altered synapse morphol-
ogy can also reﬂect the strength and stability of a synapse owing to
the associated size of the post-synaptic density, the site of synap-
tic transmission reception. In general, larger, mushroom-shaped
spines are associated with larger post-synaptic densities, allow-
ing for more stable and stronger synaptic transmission. This is
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FIGURE 1 | miRNAs regulate structural and synaptic plasticity by
targeting synaptic spine proteins. Many miRNAs promote decrease in
spine volume and/or glutamate receptor density (left) while only miR-132 has
been shown to promote spine maturation (right). Colored dots next to miRNA
indicate the target(s) of each miRNA shown to modulate plasticity. See text
for details on individual miRNA targets.
in contrast to the more dynamic ﬁlopodia-type spines, which are
associated with weak or absent synaptic transmission (Yoshihara
et al., 2009).
One of the ﬁrst synaptically enriched miRNAs identiﬁed,
miR-134, was shown to be a negative regulator of synaptic spine
volume (Schratt et al., 2006). This pioneering study showed that
miR-134 acts by repressing Limk1 expression, a kinase that reg-
ulates spine morphology by regulating ADF/coﬁlin interactions
with the actin cytoskeleton. The reduced spine volume associ-
ated with miR-134 overexpression should lead to reduced synaptic
strength. Consistent with this hypothesis, mice overexpressing
miR-134 show defects in the establishment of long-term poten-
tiation (LTP) in the hippocampus (Gao et al., 2010). However, in
this study the authors identiﬁed cAMP-response element bind-
ing protein (Creb) as a target of miR-134. It is conceivable that
both studies found true, but different targets of miR-134: the low
level of sequence complementarity required to guide a miRNA to
its target means that every miRNA has potentially hundreds of
targets. This highlights the somewhat arbitrary process of target
identiﬁcation for miRNAs when performing phenotypic analysis
of miRNA overexpression or knockdown. Importantly, both stud-
ies found that inhibition of miR-134 increased levels of Limk1
and Creb, respectively, and reversed the synaptic and structural
plasticity effects observed when miR-134 is overexpressed.
Structural plasticity-related mRNAs seem to be a prominent
target for miRNAs. This observation is supported by a study
by Chi et al. (2009) where neural miRNA targets were identiﬁed
using an unbiased biochemical approach called high-throughput
sequencing of RNAs isolated by crosslinking immunoprecipitation
(HITS–CLIP). In this approach, the AGO protein was UV-
crosslinked to its mRNA targets in a cell suspension derived from
the cortex of young mice. The crosslinked mRNA–miRNA–AGO
ternary complexes were immunoprecipitated and the RNAs from
this puriﬁcation were subject to high-throughput sequencing.
Gene ontology analysis of target mRNAs revealed an enrich-
ment of genes involved in cytoskeleton regulation, particularly
overlapping with genes also identiﬁed as involved in neuronal
differentiation.
The enrichment of miRNA targeting structural plasticity-
related genes is found prominently throughout the literature.
Actin related protein 2/3 complex, subunit 3 (Arpc3) was iden-
tiﬁed as a miR-29a/b target in a screen for miRNAs involved in
drugs of abuse-related plasticity (Lippi et al., 2011). Overexpres-
sion of miR-29a/b increased ﬁlopodia-type spines and decreased
mushroom-type spines. This spine phenotype is consistent with
the phenotype observed when Arpc3 is knocked down. As pre-
dicted by the change in morphology of spines, there is a reduction
in miniature excitatory post-synaptic current (mEPSC) frequency
when miR-29a/b is overexpressed. The activity-induced miR-
132 seems to have an opposite impact on structural plasticity.
Knockdown of miR-132 activity in newborn neurons in the adult
hippocampus or in neurons of the visual cortex leads to a reduc-
tion in stable mushroom spines and an increase in ﬁlopodia-type
spines (Luikart et al., 2011; Mellios et al., 2011). These struc-
tural changes were accompanied by decreased frequency, but not
amplitude of mEPSCs. Conversely, infusion of miR-132 mimics
into the visual cortex following monocular deprivation increased
mushroom-type spines and eliminated ocular-dominance associ-
ated plasticity (Tognini et al., 2011). The precise level of miR-132
seems to play an important role in plasticity – modest overex-
pression in the hippocampus improves performance in a Barnes
maze test without altering spine density. However, when expressed
at supraphysiological levels, miR-132 impairs performance in this
memory task, which is accompanied by increased spine density
(Hansen et al., 2013). It is worth noting that the target protein(s)
that mediate this miR-132-dependent structural plasticity have yet
to be identiﬁed.
Functional screening of synaptically enriched miRNA iden-
tiﬁed an interaction between miR-138 and the acyl protein
thioesterase 1 (Apt1) mRNA (Siegel et al., 2009). Inhibition of
miR-138 was the only synaptically enriched miRNA out of 11
tested to signiﬁcantly increase the volume of dendritic spines of
cultured hippocampal neurons. Surprisingly, this increased vol-
ume was accompanied by decreased mEPSC amplitude, which
the authors ascribe to a decrease in GluR2 positive clusters found
on the dendritic spines. Knockdown of the miR-138 target Apt1
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recapitulates the effects on spine density observed in miR-138
overexpression, suggesting that miR-138 acts through Apt1 to
regulate spine morphology.
The miRNA regulation of structural plasticity extends beyond
the hippocampus and cortex. Auditory fear conditioning down-
regulates a number of miRNA in the amygdala (Griggs et al.,
2013). Bioinformatic analysis suggested that of these downreg-
ulated miRNAs, miR-182 could bind to the 3′UTR of a number
of key regulators of the actin cytoskeleton in synapses. Infusion
of miR-182 mimics into the lateral amygdala led to downregu-
lation of RAC1, cortactin, and to a lesser extent, coﬁlin. This
same infusion protocol impaired long-term amygdala-dependent
fear memory suggesting that the miR-182 plays a repressive role
in memory formation. However, how precisely miR-182 impacts
structural or synaptic plasticity remains to be determined.
In addition to regulating the structural aspects of den-
dritic spines, a number of miRNAs have been shown to
directly regulate components of the post-synaptic density. The
synaptically enriched miR-181a can target the GluR2 subunit
of the 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic
acid receptor (AMPAR) through a conserved binding site in its
3′UTR (Saba et al., 2012). Interestingly, miR-181a is induced
by dopamine D1/5 receptor agonist SKF-38393 in vitro and by
amphetamine and cocaine in various anatomical structures in vivo.
Surface levels of GluR2 are reduced in neurons overexpressing
miR-181a; however, only mEPSC frequency and not amplitude
is affected. The authors suggest that AMPAR-dependent spine
development might be effected, explaining reduced mEPSC fre-
quency. However, the possibility remains that miR-181a may have
additional relevant targets in hippocampal neurons.
A number of mRNAs encoding post-synaptic density proteins
appear to be shared targets of miRNAs and the fragile-X men-
tal retardation protein (FMRP). The FMRP negatively regulates
mRNA translation by directly interacting with target mRNAs. In
one study, the authors identiﬁedmiRNAenriched inFMRP-bound
RNA immunoprecipitation experiments (Edbauer et al., 2010). Of
thesemiRNAs enriched on FMRP-boundmessages,miR-125b and
miR-132 had signiﬁcant effects on structural and synaptic plas-
ticity when overexpressed. While miR-125b overexpression led
to thinner spines and decreased amplitude of mEPSC, miR-132
overexpression led to the formation of short, thicker spines and
increased mEPSC amplitude and frequency, roughly consistent
with the miR-132 studies described above. Turning their focus
to miR-125b, the authors identiﬁed the N-methyl-D-aspartate
(NMDA) receptor 2A (NR2A) as a direct miR-125b target. Over-
expression and knockdown of miR-125b had signiﬁcant impact
on the NMDAR currents, consistent with the observed up and
downregulation of NR2A.
A second study found that the FMRP-bound PSD-95 tran-
script is under the regulation of miR-125a (Muddashetty et al.,
2011). Interference with miR-125a induces increased PSD-95
and increased spine number. The FMRP-bound transcripts are
translationally repressed and in many cases reactivated for trans-
lation by activity through the metabotropic glutamate receptors
1 and 5 (mGluR1/5; Darnell and Klann, 2013). Muddashetty
et al. (2011) demonstrate that the PSD-95 mRNA is liberated
from RISC following stimulation with the mGluR1/5 agonist
dihydroxyphenylglycine (DHPG). Interestingly, both the study of
Edbauer et al. (2010) and Muddashetty et al. (2011) found that
FMRP was required for miRNA-mediated silencing of their tar-
gets. Although previous studies in Drosophila have shown physical
interaction between RISC and FMRP (Ishizuka et al., 2002; Jin
et al., 2004), current data suggest thatmammalianRISCandFMRP
do not physically interact. More likely, FMRP acts to create a per-
missive environment on the mRNA that allows RISC to bind and
silence its targets. One way in which FMRP may accomplish this
is by stalling translating ribosomes (Darnell et al., 2011), prevent-
ing ribosomes from dislodging RISC from coding sequence target
sites. While most effective miRNA target sites are in the 3′UTR
of genes, there is evidence of extensive RISC binding in cod-
ing regions (Chi et al., 2009; Helwak et al., 2013). Alternatively,
FMRP binding in 3′UTRs could occlude the binding of other
RNA-binding proteins that could otherwise dislodge RISC from
its target.
NEURONAL ACTIVITY ALTERS miRNA BIOGENESIS
The miRNA biogenesis is a multiple-step process that begins with
the transcription of a primary miRNA transcript (pri-miRNA;
Krol et al., 2010b). The pri-miRNA can be derived from a non-
coding transcript containing one or many miRNAs, or can be
processed from intronic sequences. A hairpin structure containing
the mature miRNA sequence is recognized by the microproces-
sor complex, which cleaves the hairpin out of the context of the
pri-miRNA transcript, yielding a miRNA precursor (pre-miRNA).
The 60–80 nt pre-miRNA is processed by the RNase III protein
Dicer to produce a double-stranded 19–23 bp miRNA. Then one
strand is selectively loaded into AGO, yielding a mature miRNA
engaged in RISC. Each of these steps are potential control points
for the regulation of the cellular miRNA milieu. In this section,
we will review how neuronal activity regulates the steps of miRNA
biogenesis (Figure 2).
Activity has a strong inﬂuence on the transcriptional state of
neurons. Creb is one of the primary transcriptional activators that
respond to neuronal activity. In a genome-wide screen for Creb
binding sites, Vo et al. (2005) identiﬁed two consensus binding
sites near the miR-212/miR-132 locus. Stimulation of primary
neurons with brain-derived neurotrophic factor (BDNF; Vo et al.,
2005), KCl depolarization, or bicuculline (Wayman et al., 2008)
all induce the production of pri-miR-132 transcript, making it the
ﬁrst recognized miRNA whose expression is regulated by neuronal
activation. These observations have been supported by numer-
ous in vivo investigations (Nudelman et al., 2010; Eacker et al.,
2011; Mellios et al., 2011; Tognini et al., 2011; Wang et al., 2013)
among others. Regulation through the cAMP response elements
in the putative promoter region of the miR-212/miR-132 clus-
ter were further conﬁrmed by the activity-dependent acquisition
of transcription-promoting chromatin marks in the visual cor-
tex after visual stimulation (Tognini et al., 2011). Coupled with
the potent effects of miR-132 on structural and synaptic plasticity
(see above), it’s activity-dependent transcriptional control sug-
gests that miR-132 is a potent regulator of experience-dependent
plasticity in vivo.
A second, larger cluster of miRNAs, the miR-379∼410 clus-
ter, has also shown to be upregulated by neuronal activity (Fiore
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FIGURE 2 | Neuronal activity influences miRNA expression through
multiple mechanisms. Activity-dependent transcription induces miRNA
production through Mef2 and Creb while Lin28a increases expression
through an uncertain combination of transcription-dependent and
-independent mechanisms. Increased levels of Lin28a lead to
destabilization of pre-let-7 transcripts through poly-uridynylation. Activity
also promotes accelerated miRNA turnover through an additional
unknown mechanism(s). Activity-dependent phosphorylation of TRBP
stabilizes Dicer, leading to increased mature miRNA production.
NMDAR-activation promotes the ubiquitinylation of MOV10, a component
of RISC, which may lead to decreased levels of mature-miRNA loaded RISC.
See text for details.
et al., 2009). This miRNA cluster is regulated both by BDNF and
KCl depolarization via the myocyte enhancing factor 2 (Mef2)
transcription factor. Among the many miRNAs transcribed from
this locus is miR-134, a known regulator of structural plastic-
ity through Limk1. In addition to directly regulating Limk1, this
study suggests miR-134 may play a broader role in regulating pro-
tein synthesis by regulating the RNA binding protein Pumilio 2
(Pum2).
Increased expression of pri-miRNA transcript does not nec-
essarily result in increased mature miRNA levels. One striking
example of how neuronal activity can inﬂuence mature miRNA
levels independently of transcription is through the induction
the Lin28a RNA binding protein by BDNF (Huang et al., 2012).
The Lin28 family members can selectively impair the process-
ing of both pri- and pre-let-7 miRNA, though Lin28a primarily
targets pre-let-7 through the post-transcriptional additionof poly-
uridine to the 3′ end of the transcript (Thornton and Gregory,
2012). In response to bath application of BDNF in the presence of
actinomycin D, hippocampal neurons show increased expression
of Lin28a leading to a decrease in mature let-7 levels, resulting to
increased translation of let-7 target RNAs. Under the same stim-
ulating conditions, Huang et al. (2012) observed an increase in
pre-miRNA processing of non-let-7 miRNA. This was the result
of increased phosphorylation of the Dicer binding partner trans-
activation response RNA-binding protein (TRBP). The extracel-
lular signal-regulated kinase (ERK)-dependent phosphorylation
of TRBP stabilizes Dicer (Paroo et al., 2009), and in the con-
text of BDNF stimulation leads to increased levels of pre-miRNA
processing.
While activity induced by BDNF may lead to increased process-
ing of pre-miRNA, activity through glutamate receptors seems to
accelerate mature miRNA turnover (Krol et al., 2010a). Using a
variety of transcriptional inhibitors, Krol et al. (2010a) demon-
strated that neuronal miRNAs have an unusually high turnover
rate compared to other cell types. The turnover rate was further
accelerated by addition of glutamate and decelerated by the appli-
cation of to tetrodotoxin (TTX). These ﬁndings are strikingly
similar to those made in Aplysia where application of serotonin
results in the rapid degradation of miR-124 (Rajasethupathy et al.,
2009). The mechanism for this rapid, activity-dependent miRNA
turnover remains unclear. However, it is worth noting that at
timepoints distal to neuronal activation, there are many more
miRNAs that are downregulated than upregulated over a num-
ber of array-based studies (Eacker et al., 2011; Jimenez-Mateos
et al., 2011; Griggs et al., 2013; Risbud and Porter, 2013). This
activity-dependent miRNA turnover may allow neurons to rapidly
reprogram RISC in a global manner in a way that promotes
synaptic plasticity.
There is growing evidence that pre-miRNA processing can
occur in dendrites. Biochemical puriﬁcation of RISC compo-
nents from synaptosomes showed detectable levels of pre-miRNA
(Lugli et al., 2008). Recently, in situ hybridization methods that
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allow for speciﬁc detection of pre-miRNA have lent credence to
the possibility that dendritically localized pre-miRNA may be an
important phenomenon (Bicker et al., 2013). Using a clever bio-
chemical approach, the authors of this study identiﬁed DHX36, a
DExH-box RNA helicase as an interactor with the loop region of
the dendritically localized pre-miR-134 transcript. Knockdown of
DHX36 reduceddendritic transport of pre-miR-134 and enhanced
the translation of reporters of miR-134 activity. The authors pro-
pose that DHX36 stabilizes pre-miR-134 for dendritic processing,
perhaps in an activity-dependent manner, though this remains to
be determined.
The Drosophila protein Armitage (Armi) and its mammalian
homolog MOV10 are both implicated in the activity-dependent
relief of miRNA repression (Ashraf et al., 2006; Banerjee et al.,
2009). Armi and MOV10 are DExH-box RNA helicases that have
been shown to be components of RISC (Tomari et al., 2004;
Meister et al., 2005). In the case of Drosophila, Armi is degraded
via the ubiquitin proteasome following activation of the nicotinic
acetylcholine receptor. In mammals, MOV10 is also degraded in
a proteosomal-dependent manner in response to NMDA receptor
activation (Banerjee et al., 2009; Jarome et al., 2011). In neurons,
degradation of MOV10/Armi relieves miRNA-mediated repres-
sion by an unknown mechanism, allowing for the translation
of mRNAs involved in synaptic plasticity (Ashraf et al., 2006;
Banerjee et al., 2009). Biochemical data concerning Armi’s func-
tion suggest that it is required for the loading of AGO with
mature miRNAs following Dicer processing (Tomari et al., 2004).
However, recent genome-wide studies have identiﬁed numerous
promiscuous interactions between polyadenylated mRNAs and
MOV10 (Castello et al., 2012; Sievers et al., 2012), suggesting addi-
tional potential interactions of MOV10 and miRNA-mediated
silencing. More research is required to elucidate this poten-
tially important interface between the relief of miRNA-mediated
repression and activity-dependent protein synthesis.
miRNAs FUNCTION IN DISEASES OF NEURONAL
OVEREXCITATION
Excessive neuronal activity is associated with neuronal cell death
in a number of contexts. During stroke, neuronal depolarization
leads to excess glutamate release that cannot be compensated for
by normal reuptake mechanisms. The resulting excess glutamate
results in glutamate receptor hyperactivation and excitotoxic cell
death via excess calcium inﬂux. As miRNAs are potent regulators
of the cellular stress response (Leung and Sharp, 2010; Mendell
and Olson, 2012) and neuronal excitability (see above), they are
a logical target for the investigation and enhancement of intrinsic
neuroprotective pathways (Figure 3). A fair amount of effort has
been made toward understanding the global miRNA response to
stroke in rodent models. These studies generally rely on compar-
isons of RNA samples from stroke and sham brains, and subject
them to some type of high-throughput array. Not surprisingly, the
resultingmiRNAexpression proﬁles between different experimen-
tal stroke conditions, different laboratories, and different array
platforms show almost no overlap. Despite this lack of overlap,
there is valuable information that can be gained fromabrief review
of these studies.
FIGURE 3 | Potential targets for miRNA-mediated therapies in the
treatment of stroke and epilepsy. Potential interventions target miRNAs
to either reduce excitotoxic calcium inﬂux (top) or reduce the impact of
excessive calcium inﬂux (bottom). Potential miRNA targets and be inﬂuenced
either by introduction therapeutic inhibitors (red x) or mimics (green check).
See text for details. Note: Conﬂicting results of miR-134 inhibition on spine
morphology with embryonic neuronal studies described above. See text for
details.
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One of the best studies that highlights the complexity of the
miRNA response to CNS injury was performed on both blood and
brain tissue from rats after ischemic stroke, intracerebral hemor-
rhage, or kainic acid-induced excitotoxicity (Liu et al., 2010). In
this study, relatively few miRNAs showed consistent changes in
expression in either brain tissue or blood. However, three miR-
NAs found in the blood (miR-155, miR-298, and miR-362-3p)
change expression greater than twofold in response to some of the
injuries. This suggests that expression of some miRNAs might be
useful biomarkers to identify subtypes of CNS injuries.
In two related studies, the miRNA cortex of mice treated
with middle cerebral artery occlusion (MCAO) model of stroke
were proﬁled either by PCR 24 h post-stroke (Yin et al., 2010)
or by array over an extended time course (Dharap et al., 2009).
There was no signiﬁcant overlap found between these two stud-
ies, perhaps because of methodological differences. Each study
did identify some miRNAs that showed reproducible changes in
their model. In one case, the authors found that miR-145 showed
signiﬁcant and enduring upregulation following stroke (Dharap
et al., 2009). Inhibition of miR-145 with chemically modiﬁed anti-
sense oligonucleotides (so-called antagomirs, or anti-miRs) lead
to upregulation of superoxide dismutase 2, a predicted miR-145
target gene. Whether miR-145 inhibition had any therapeutic
beneﬁt was not determined. In the second study, the authors
identiﬁed miR-497 as an upregulated miRNA in cortex following
MCAO and in neuroblastoma cells subjected to oxygen–glucose
deprivation (OGD), a cell culture model of stroke (Yin et al.,
2010). Through a series of experiments, the authors show that
Bcl-2 and Bcl-w, two anti-apoptotic molecules are targets of
mIR-497. Infusion with antagomirs targeting miR-497 prior to
MCAO resulted in reduced infarct volume and reduction in the
severity of neurological deﬁcits. Similar results were observed
for mIR-29b, another miRNA which targets Bcl-w (Shi et al.,
2012). The authors observed an increase in miR-29b follow-
ing MCAO and showed that simple overexpression of miR-29b
lead to spontaneous neuronal cell death in a Bcl-w-dependent
manner.
Another approach toward ﬁnding potentially therapeutic miR-
NAs for treating stroke is to work backward from a known
therapeutic target or pathway and identify miRNA interactors.
GRP78 (also known as BIP) is a chaperone that is primarily local-
ized to the ER and plays a key role in the ER-stress response.
Ouyang et al. (2012) found that decreased GRP78 levels were
accompanied by increased miR-181 in the core of MCAO-induced
infarctions. After establishing that miR-181 could directly tar-
get GRP78, the author demonstrated that inhibition of mIR-181
through pretreatment with antisense oligo could signiﬁcantly
reduce infarct volume following MCAO. A similar approach iden-
tiﬁed miR-320a as a regulator of aquaporins 1 and 4 (AQ1 and
AQ4) (Sepramaniam et al., 2010). Reduced expression of AQ1 and
4 in actrocytes is associated cerebral edema. By inhibiting miR-
320a with antisense oligonucleotides, there was an increase inAQ1
and 4 expressions and a reduction in MCAO infarct volume.
Our lab recently investigated the role of miR-223 in neuro-
protection motivated by the disproportionate number of nervous
system targets predicted to be miR-223 targets (Harraz et al.,
2012). Bioinformatic predictions identiﬁed that miR-223 should
target glutamate receptor subunits NR2B and GluR2, making it a
candidate for protection against excitotoxic insult. Targeted muta-
tion of miR-223 leads increased levels of GluR2 and NR2B in the
hippocampus, but not other post-synaptic proteins, and increased
mEPSC decay time and amplitude. Consistent with these ﬁnd-
ings, miR-223 knockdown increased NMDAR-dependent calcium
inﬂux while overexpression decreased inﬂux. Overexpression of
miR-223 was protective across brain regions, protecting the stria-
tum from NMDA-induced excitotoxicity and hippocampus from
bilateral common carotid artery occlusion. Importantly miR-223
mutant mice were highly sensitized to both of these injuries,
establishing a deﬁnitive role for miR-223 in the endogenous
neuroprotective program.
Excitotoxicity also plays an important role in cell death asso-
ciated with temporal lobe epilepsy (TLE), a chronic intractable
form of epilepsy. TLE can be modeled in rodents by injection
of pilocarpine, a muscarinic acetylcholine receptor agonist or
injection of kainic acid, an agonist of the kainate-type gluta-
mate receptor. Injection of either of these compounds results
in establishment of status epilepticus (SE) in rodents. A num-
ber of studies have proﬁled miRNA from the hippocampus of
mice following establishment of SE. Two studies from different
research groups using kainic acid (Sano et al., 2012) and pilo-
carpine (Hu et al., 2012) model, respectively, found SE-associated
upregulation of miR-34a in the hippocampus. MiR-34a expression
is associated with p53-dependent pro-apoptotic program (Chang
et al., 2007), making its upregulation by SE an attractive target
for TLE therapy. Though both groups observed elevated caspase 3
cleavage associated with overexpression of miR-34a, only Hu et al.
(2012) observed a protective effect by inhibiting miR-34a. Though
methodological differences may explain some of the differences
between these results, a robust and reproducible protective effect
would be necessary to warrant further investigation of miR-34a in
TLE therapeutics.
Two activity-regulated miRNAs, miR-132 and miR-134, are
both upregulated in mouse models of TLE (Jimenez-Mateos et al.,
2011, 2012). Interestingly, miR-132 induction in this TLE model
is suppressed when mice are preconditioned with a low, periph-
erally administered dose of kainic acid (Jimenez-Mateos et al.,
2011). This suggests that impairing miR-132 expression, by what-
ever means, may be neuroprotective. Indeed this was the case:
inhibition of miR-132 by infusion of miR-132 antagomirs before
kainic acid injection reduced cell death in the CA3 subﬁeld of
the hippocampus. Given the evidence from the synaptic plasticity
ﬁeld regarding miR-132’s ability to stimulate stable mushroom-
type dendritic spines suggests that anti-miR-132 treatments may
reduce cell death by reducing hippocampal neuron’s excitability,
and therefore susceptibility to excitotoxicity. Similarly, miR-134
inhibition with antagomirs prior to SE induction provided neuro-
protection. However, unlike miR-132 inhibition, a single injection
of miR-134 antagomir provided long-lasting inhibition of recur-
rent spontaneous seizures (Jimenez-Mateos et al., 2012). Building
on the work of Schratt et al. (2006), this study demonstrated that
anti-miR-134 treatment reduced spine density in vivo, likely acting
via Limk1. The long-lasting nature of the anti-miR-134 protection
suggest that miR-134-based therapeutic may hold promise in
treating intractable TLE.
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CONCLUSIONS AND FUTURE STUDIES
In the relative short time since their discovery, the miRNA ﬁeld
has made a dramatic impact on our understanding of nervous
system function. Insights concerning the mechanisms of synap-
tic plasticity have been of particular interest, potentially coupling
activity-dependent synaptic plasticity and protein synthesis. The
local translationof proteins has longbeen considered amechanism
for regulating the connections at individual synapses and miRNA
may be a key regulator at this point (Sutton and Schuman, 2006).
However attractive this hypothesis is, there have been no clear
demonstrations thatmiRNAcan regulate local, activity-dependent
protein synthesis. Furthermore, while there is some evidence that
miRNA can sequester mRNAs from translating ribosomes, it is
not clear that sequestered mRNA can undergo reactivation. In
some studies, investigators observe a decrease in miRNA-targeted
mRNA levels consistent with the deadenylation and decay model
while other see only a change in protein levels, more consistent
with a sequestration model. While a difﬁcult problem to interro-
gate, understanding local control of protein synthesis by miRNA
should be a central focus of future investigations.
As discussed above, individual miRNAs can have potentially
hundreds of targets owing to the small amount of complementar-
ity required to establish miRNA–mRNA interactions. In virtually
all studies, there is a focus on a one miRNA–one target inter-
action. This is largely for practical purposes – requirements for
publication dictate a laser-like focus on a making a bulletproof set
of observations. While editors and reviewers require this type of
focus, miRNAs do not have such single-minded focus (Baek et al.,
2008; Selbach et al., 2008). Having a more comprehensive view of
how individual miRNAs regulate the proteome will be necessary,
especially if they are to be used in therapeutics.
Virtually all the studies described in this review rely on antisense
oligonucleotides or antagomirs to conduct loss-of-function exper-
iments. While these reagents are widely used and proven effective
under many circumstances, virtually nothing is known about their
distribution and perdurance in the CNS following intracranial
injection, making interpretation of how they work problematic. A
reasonable complement to antagomir application would the use of
traditional targeted mutations, which are becoming increasingly
more available to the general scientiﬁc research world (Park et al.,
2012).
Finally, the most successful candidate miRNAs for translation
to the clinic have arisen from rigorous work in the basic sciences.
Both miR-132 and miR-134 have a long track record of careful
investigation in the basic synaptic plasticity ﬁeld and have now
been shown to have potential in the treatment of epilepsy. This
cross-pollination of basic and translational science seems to be
the most fruitful way forward for the future of miRNA-based
therapeutics.
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